Keheala Chosen To Represent Israel At The 2019 World Summit Awards
Patient-centered and clinician desired, Keheala's digital health platform extends the healthcare system's reach by directly empowering patients.
(August 30th, 2018 – Nairobi and Tel Aviv) Digital health company, Keheala, announced today that it has been selected to represent Israel at the 2019 World Summit Awards. Each year, 10.4 million patients are infected with tuberculosis (TB) while 1.8 million patients die from the curable disease. Keheala is determined to change these statistics.
Founded in 2016 by a multidisciplinary team of doctors, engineers and business professionals, the company delivers powerful behavioral interventions using mobile phones and other digital platforms. Patient stigmatization, coupled with a lack of information, motivation and support combine to unnecessarily burden TB sufferers. Healthcare systems often lack the resources or expertise to address these non-medical drivers of disease, which exist outside of healthcare facilities.
With Keheala, however, patients receive disease management tools and behavioral nudges to keep them on track during the lengthy treatment period. Healthcare providers can access data and analytics to better focus their limited resources and combat epidemics early on. In a 1,200 patient randomized controlled trial, Keheala reduced the unsuccessful TB health outcomes (death, failed treatment and loss to follow up) by 68%.
The World Summit Awards selects local digital innovations that have a high impact on improving society: acting as a quality seal for companies with societal impact in over 180 participating countries.
Jon Rathauser, CEO and Founder of Keheala said: “We are thrilled to have been chosen to represent Israel at the 2019 World Summit Awards. In the fight against TB, improper adherence leads to retreatment, transmission and drug resistance. To that end, we will continue our work with life improving behavioral interventions.”
Keheala is now helping TB patients in Zimbabwe and scaling existing projects in Kenya. For more information on Keheala and their work, or to become a partner for new use-cases like HIV, diabetes and hypertension, please contact firstname.lastname@example.org.